Review Note
Last Update: 08/30/2023 12:42 AM
Current Deck: ACMS Study Guide Deck::A. Cancers
Published
Fields:
Front
Pembrolizumab what is it and MOA
Back
Monoclonal IgG4 antibody targeting PD-1 (treats SCC)
▪ Antibody binds to PD-1 receptor and blocks interaction with PD-L1
and PD-L2
▪ Antibody binds to PD-1 receptor and blocks interaction with PD-L1
and PD-L2
Tags:
Suggested Changes:
Deck Changes (Suggestion to move the Note to the following Deck):
Field Changes:
Tag Changes: